ArticleEuropean journal of endocrinology2022

Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.

Steven G Waguespack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.